[Bronchospasm, apnea and heart arrest following dipyridamole perfusion scintigraphy].
The occurrence of fatal respiratory insufficiency following dipyridamole-thallium imaging is described. The patient, a 67-year-old man, had a history of chronic obstructive lung disease. Since patients with a history of chronic obstructive lung disease have an increased risk of developing bronchospasm after dipyridamole infusion, it is advised to be cautious in performing dipyridamole-thallium imaging in these patients. Dobutamine may be an acceptable alternative to dipyridamole in these patients.
Ottervanger
J P
JP
Afd. Cardiologie, Ziekenhuis De Weezenlanden, Zwolle.
Haan
D
D
Gans
S J
SJ
Hoorntje
J C
JC
Stricker
B H
BH
D000368:Aged; D001049:Apnea / Q000139:chemically induced*; D001986:Bronchial Spasm / Q000139:chemically induced*; D004176:Dipyridamole / Q000009:adverse effects*; D006323:Heart Arrest / Q000139:chemically induced*; D006801:Humans; D008173:Lung Diseases, Obstructive / Q000175:diagnosis; D008297:Male
D004176:Dipyridamole